Insilico Medicine Announces Positive Topline Results of the Ne...
- Written by LATEST ASIANET NEWS RELEASES
- Published in Asia Net
NEW YORK and HONG KONG, Jan. 10, 2023 /PRNewswire-AsiaNet/ -- Insilico Medicine, a clinical stage artificial intelligence (AI)-driven drug R&D company, today announces positive topline results of safety, tolerability, and pharmacokinetics (PK) from the Phase I clinical trial of INS018_055(https://clinicaltri...
Authors: LATEST ASIANET NEWS RELEASES